Prognostic indices in diffuse large B-cell lymphoma in the rituximab era: an analysis of the UK National Cancer Research Institute R-CHOP 14 versus 21 phase 3 trial
| Image |  |
|---|---|
| Description | scientific article published on 20 May 2020 |
| Author/s |
author: Mary Gleeson Eliza A Hawkes David C Linch Kirit M. Ardeshna |
| Publication date | May 20, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |